Sign in

CIK 0001851484

  • Emerging growth company

CITIUS ONCOLOGY, INC.

Sign in to watch
Ticker
CTOR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
DE
Entity type
Operating
EIN
994362660
Phone
+1 908-967-6677
Business address
11 COMMERCE DRIVE, 1ST FLOOR, CRANFORD, NJ, 07016
Former names
TenX Keane Acquisition
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-12 Webb Carol Director Grant or award · Stock Option (Right to Buy) +125,000 125,000
2025-09-19 Webb Carol Director Grant or award +300,000 300,000
2025-09-19 Webb Carol Director Grant or award +300,000 300,000
2025-09-19 Webb Carol Director Grant or award +300,000 300,000
2024-12-12 Webb Carol Director Grant or award · Stock Option (Right to Buy) +125,000 125,000
2024-08-12 Webb Carol Director Grant or award · Stock Option (Right to Buy) +150,000 150,000

Page 1 of 1 · 6 trades